Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Nathan J Liu"'
Autor:
Paul B Chapman, Nathan J Liu, Qin Zhou, Alexia Iasonos, Sara Hanley, George J Bosl, David R Spriggs
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0184025 (2017)
Very little is known about the proportion of oncology trials that get published, the time it takes to publish them, or the reasons why oncology trials do not get published.We analyzed all clinical trials that closed to accrual at our cancer center be
Externí odkaz:
https://doaj.org/article/d3f2222b62674e2480503bc91d1e4eee
Autor:
Nathan J. Liu, Philip E. Hess
Publikováno v:
DeckerMed Transitional Year Weekly Curriculum™.
Publikováno v:
International Journal of Obstetric Anesthesia. 42:57-60
Evidence to guide clinical decision-making in pregnant women who are usually asymptomatic, but identified as heterozygote carriers of F11 mutations, is lacking. We hypothesized that women identified on prenatal screening as heterozygous for a mutatio
Publikováno v:
Critical Reviews in Toxicology. 47:225-262
Little consistency exists in the methodology for toxicological testing of aerosolized nanoparticles used in in vitro, air-interfaced culture (AIC) exposure systems for engineered nanoparticles (ENPs) risk-assessment, preventing inter-laboratory compa
Autor:
Alexa Juarez, Jane Jarjour, Steven A. Abrams, Nathan J. Liu, Renata F. Ramos, Denizen K. Kocak, Keli M. Hawthorne, Mika M. Tabata
Publikováno v:
Nutrients, Vol 7, Iss 6, Pp 5051-5064 (2015)
Nutrients
Volume 7
Issue 6
Pages 5051-5064
Nutrients
Volume 7
Issue 6
Pages 5051-5064
Continuous infusion systems used for enteral nutrition support in the neonatal intensive care unit deliver as little as 60% of the fat in human milk to the neonate. This study determined the effect of mixing common feedings for preterm infants in the
Autor:
Nastassja A, Lewinski, Nathan J, Liu, Akrivi, Asimakopoulou, Eleni, Papaioannou, Athanasios, Konstandopoulos, Michael, Riediker
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1570
The field of nanomedicine is steadily growing and several nanomedicines are currently approved for clinical use with even more in the pipeline. Yet, while the use of nanotechnology to improve targeted drug delivery to the lungs has received some atte
Autor:
Michael Riediker, Nathan J. Liu, Athanasios G. Konstandopoulos, Nastassja Lewinski, Eleni Papaioannou, Akrivi Asimakopoulou
Publikováno v:
Methods in Molecular Biology ISBN: 9781493968381
The field of nanomedicine is steadily growing and several nanomedicines are currently approved for clinical use with even more in the pipeline. Yet, while the use of nanotechnology to improve targeted drug delivery to the lungs has received some atte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e457f389ee27e8209afa6700cc72783d
https://doi.org/10.1007/978-1-4939-6840-4_21
https://doi.org/10.1007/978-1-4939-6840-4_21
Autor:
Molly M. Stevens, Yiyang Lin, Natalie Philips, Matthew Tyreman, Nathan J. Liu, Robert Chapman, Shahid A. Khan, Andrew Bentham
Acute pancreatitis is a relatively common and potentially fatal condition, but the presenting symptoms are non-specific and diagnosis relies largely on the measurement of amylase activity by the hospital clinical laboratory. In this work we develop a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8ac6a53da59f8a0c8b5fc7b0eb45178
http://hdl.handle.net/10044/1/33677
http://hdl.handle.net/10044/1/33677
Autor:
Robert Chapman, Jonas Mmesi, Matthew Tyreman, Nathan J. Liu, Molly M. Stevens, Sonya Abraham, Andrew Bentham, Yiyang Lin
Secretory phospholipase A2 group IIA (sPLA2-IIA) was examined as a point of care marker for determining disease activity in rheumatoid (RA) and psoriatic (PsA) arthritis. Serum concentration and activity of sPLA2-IIA were measured using in-house anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12dad61b1fafd472e2806ba7f9e342bc
http://hdl.handle.net/10044/1/29634
http://hdl.handle.net/10044/1/29634
Autor:
Sara Hanley, David R. Spriggs, Paul B. Chapman, Nathan J. Liu, Alexia Iasonos, George J. Bosl, Qin Zhou
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0184025 (2017)
PLoS ONE
PLoS ONE
Background Very little is known about the proportion of oncology trials that get published, the time it takes to publish them, or the reasons why oncology trials do not get published. Methods We analyzed all clinical trials that closed to accrual at